Gareev, I,
Gileva, Y,
Dzidzaria, A,
Beylerli, O,
Pavlov, V,
Agaverdiev, M,
Mazorov, B,
Biganyakov, I,
Vardikyan, A,
Jin, M,
Ahmad, A (2021) choice. Therefore, the possibility that lncRNAs could represent
innovative therapeutic agents or targets
Gareev, I.,
Gallyametdinov, A.,
Beylerli, O.,
Valitov, E.,
Alyshov, A.,
Pavlov, V.,
Izmailov, A.,
Zhao, S. (2021) was named "2019 novel coronavirus infection" (COVID-19). Telemedicine
technologies are a form of medical
ТРАНСПЛАНТАЦИОННЫЕ ТЕХНОЛОГИИ В ЛЕЧЕНИИ БУЛЛЕЗНОЙ КЕРАТОПАТИИTRANSPLANTATION
TECHNOLOGIES IN THE TREATMENT OF BULLOUS KERATOPATHY
EchoNavigator (R)
technology facilitates transapical mitral paravalvular leak closure: a case